Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease | Zendy

Haluk Tarık Kani | Zendy; Coşkun Özer Demirtaş | Zendy; Çağlayan Keklikkıran | Zendy; İlkay Ergenç | Zendy; Shahin Mehdiyev | Zendy; Esra Akdenız | Zendy; Yusuf Yılmaz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease

Author(s) -

Haluk Tarık Kani,

Coşkun Özer Demirtaş,

Çağlayan Keklikkıran,

İlkay Ergenç,

Shahin Mehdiyev,

Esra Akdenız,

Yusuf Yılmaz

Publication year - 2021

Publication title -

the turkish journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.404

H-Index - 28

eISSN - 2148-5607

pISSN - 1300-4948

DOI - 10.5152/tjg.2021.20512

Subject(s) - medicine , metabolic syndrome , fatty liver , disease , fibrosis , gastroenterology , obesity

Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated fatty liver disease (MAFLD) is still not clear in a combined diagnosis of MS. In this study, we aimed to investigate the effect of MS on advanced fibrosis in patients with MAFLD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research